Other articles related with "R730.51":
  ZHANG Jianing, ZHANG Yi, ZHANG Xiaolian, LI Haiying, WANG Daqing
  Research progress in immunotherapy for malignant tumors
    Journal of Practical Oncology   2026 Vol.40 (1): 75-82 [Abstract] (7) [PDF 900 KB] (4)
  LIU Qianqian, SHANG Lihua
  Research progress on the correlation between immune-related adverse reactions and efficacy of immunotherapy in advanced non-small cell lung cancer
    Journal of Practical Oncology   2022 Vol.36 (5): 463-467 [Abstract] (88) [PDF 1843 KB] (19)
  TANG Ju, SHANG Lihua
  The relationship between BMI and the efficacy of immune checkpoint inhibitors in the treatment of malignant tumors
    Journal of Practical Oncology   2022 Vol.36 (2): 188-192 [Abstract] (80) [PDF 10501 KB] (34)
  ZHANG Weiming, SUN Jianping, ZHAO Yan
  Co-stimulatory receptors:potential targets for tumor immunotherapy
    Journal of Practical Oncology   2021 Vol.35 (5): 441-446 [Abstract] (89) [PDF 12059 KB] (20)
  WANG Mengmeng, LIAN Jie, LI Hengzhen, ZHANG Yanqiao
  Research progress in immunotherapy of gastrointestinal pancreatic neuroendocrine tumors
    Journal of Practical Oncology   2021 Vol.35 (2): 154-159 [Abstract] (107) [PDF 12444 KB] (44)
  HUANG Juanjuan, WANG Wenxin, CAO Fenglin
  Research progress of cellular immunotherapy for hematological malignancies
    Journal of Practical Oncology   2016 Vol.30 (1): 61-65 [Abstract] (134) [PDF 2026 KB] (182)
  WAN Jinghua,FU Zhenkun
  Reviews on association between the inhibitory costimulatory molecules B7-H4 and female malignant tumor
    Journal of Practical Oncology   2015 Vol.29 (1): 53-56 [Abstract] (143) [PDF 1655 KB] (72)
  WU Lihua,WANG Dongliang,ZHANG Yanqiao
  Myeloid-derived suppressor cells:a new target of cancer immunotherapy
    Journal of Practical Oncology   2012 Vol.26 (4): 369-372 [Abstract] (99) [PDF 2016 KB] (66)
 
 
    Journal of Practical Oncology   2011 Vol.25 (1): 18-21 [Abstract] (44) [PDF 1920 KB] (75)